Press Releases


Recensa Therapeutics Wins “Best in Show” at 1st Pitch Life Science Competition NYC

Recensa Therapeutics was named“Best in Show” and “Most Fundable” by the investor panel at MABA’s 1st Pitch Life Science NYC competition May 25, 2017 |  Source: Mid Atlantic Bio Angels NEW YORK, June 01, 2017 (GLOBE NEWSWIRE) — Mid Atlantic Bio Angels (MABA) announces today that Recensa Therapeutics (http://www.recensatherapeutics.com), which is developing a topical psoriasis treatment designed to reduce oxidative stress, was named “Best in Show” by the audience and “Most Fundable” by the investor panel at […]


BioCurrent Technologies Wins “Best in Show” at 1st Pitch Life Science Competition New Jersey

BioCurrent was named“Best in Show”at MABA’s 1st Pitch Life Science New Jersey competition April 18, 2017 |  Source: Mid Atlantic Bio Angels NEW YORK, May 01, 2017 (GLOBE NEWSWIRE) — Mid-Atlantic Bio Angels (MABA) announces today that BioCurrent Technologies (BioCurrent), a microbe-based, sustainable nanomaterials company, was named “Best in Show” by the audience and “Most Fundable” by the investor panel at MABA’s 1st Pitch Life Science New Jersey event held on April 18, 2017 at Rutgers University […]


Group K Diagnostics Wins “Best in Show” at 1st Pitch Life Science Competition Philadelphia March 20, 2017

Group K Diagnostics was named“Best in Show”at MABA’s 1st Pitch Life Science Philadelphia competition March 20, 2017 |  Source: Mid Atlantic Bio Angels NEW YORK, April 3, 2017 (GLOBE NEWSWIRE) — Mid-Atlantic Bio Angels (MABA) announces today that Group K Diagnostics (Group K), a diagnostics company developing a multi-test modular point of care diagnostic platform, was named“Best in Show”at MABA’s 1st Pitch Life Science Philadelphia event held on March 20, 2017 at the Cira Center in Philadelphia. […]


One Three Biotech Named “Best-in-Show” at New York 1st Pitch Life Science Competition March 13, 2017

OneThree Biotech Wins “Best in Show” at 1st Pitch Life Science Competition Company’s Unique Process of Drug Targeting May Significantly Decrease Time to Development March 13, 2017 |  Source: Mid Atlantic Bio Angels NEW YORK, March 23, 2017 (GLOBE NEWSWIRE) — Mid Atlantic Bio Angels (MABA) announces today that OneThree Biotech (OneThree), a New York-based company developing artificial intelligence technology to more rapidly identify drug targets and side effects, was named “Best in Show” at […]


NangioTx, Wins Mid-Atlantic Bio Angels’ “Best of the Best” Year-End 1st Pitch Life Science Competition December 6, 2016

NangioTx Wins Mid-Atlantic Bio Angels’ “Best of the Best” Year-End 1st Pitch Life Science Competition Developer of Novel Drug that Promotes the Growth of New Blood Vessels in the Muscles of Patients with Peripheral Artery Disease  Named “Best of the Best” at New York-Based Event December 13, 2016 09:45 ET | Source: Mid Atlantic Bio Angels NEW YORK , Dec. 13, 2016 (GLOBE NEWSWIRE) — Mid-Atlantic Bio Angels (MABA) announces today that NangioTx, Inc.(http://www.nangiotx.com) was voted […]


VakSea Named “Best in Show” at 1st Pitch Baltimore, October 26, 2016

VakSea Wins Mid-Atlantic Bio Angels 1st Pitch Life Science Competition in Baltimore Developer of Oral Vaccines Against Nervous Necrosis Virus in Aquaculture Named “Best in Show” at Baltimore-Based Event November 11, 2016 09:45 ET | Source: Mid Atlantic Bio Angels NEW YORK, Nov. 11, 2016 (GLOBE NEWSWIRE) — Mid-Atlantic Bio Angels (MABA) announces today that VakSea, Inc. was named “Best in Show” at MABA’s inaugural 1st Pitch Life Science Baltimore event on October 26, 2016 at […]


Lynkogen and Dina Pharmaceuticals Best-in-Show at 1st Pitch New Jersey, November 1, 2016

Lynkogen, Inc. and Dina Pharmaceuticals, Inc. Selected as Co-Winners of 1st Pitch Life Science Competition, New Jersey Lynkogen, Developer of Protein Therapeutics for Rare and Prevalent Metabolic Diseaseses, and Dina Pharmaceuticals, Developers of a Novel Therapeutic for Parkinson’s Disease, was Named “Best in Show” at New Jersey-Based Event November 10, 2016 09:45 ET | Source: Mid Atlantic Bio Angels NEW YORK, Nov. 10, 2016 (GLOBE NEWSWIRE) — Mid-Atlantic Bio Angels (MABA) announces today that Lynkogen, […]


Mid Atlantic Bio Angels Closed-End Investing Pool Makes Investment in Genome Profiling LLC (GenPro)

October 28, 2016 09:35 ET | Source: Mid Atlantic Bio Angels  NEW YORK, Oct. 28, 2016 (GLOBE NEWSWIRE) — Mid Atlantic Bio Angels (MABA) announces today that its previously announced, closed-end investment pool (Pool) funded solely by current, active MABA members, has made its second investment of the year. The investment, which was joined by several MABA members, was made in Genome Profiling LLC (GenPro), a Delaware-based company focused on epigenetic biomarker discovery. “This second […]


Bioharmony Therapeutics – October 6, 2016

Bioharmony Therapeutics Wins Mid-Atlantic Bio Angels 1st Pitch Life Science Competition Developer of a Topical Lysin Treatment That May Heal Skin and Soft Tissue Infections due to Multi-Drug Resistant Bacteria Named “Best in Show” at New York-Based Event October 18, 2016 09:45 ET | Source: Mid Atlantic Bio Angels NEW YORK, Oct. 18, 2016 (GLOBE NEWSWIRE) — Mid-Atlantic Bio Angels (MABA) announces today that Bioharmony Therapeutics (Bioharmony), a New York-based company developing a topical treatment […]


PolyAurum, Inc, 1st Pitch Winner PA – September 15, 2016

PolyAurum, Inc. Wins Mid Atlantic Bio Angels 1st Pitch Life Science Philadelphia Competition Developer of Biodegradable Gold Nanoparticles for Cancer Treatment Named as “Best in Show” September 28, 2016 08:30 ET | Source: Mid Atlantic Bio Angels PHILADELPHIA, Sept. 28, 2016 (GLOBE NEWSWIRE) — Mid Atlantic Bio Angels (MABA) announces today that PolyAurum, Inc. (http://www.polyaurum.com) was chosen as “Best in Show” at MABA’s Philadelphia 1st Pitch Life Science event, which took place at the Cira […]